Michael S. Davis, MD, MBA, MHA, FACS

University of New Mexico

Albuquerque, New Mexico

Michael S. Davis, MD, MBA, MHA, FACS, is a professor in the Department of Surgery and is chief of the Division of Urology at the University of New Mexico School of Medicine in Albuquerque, New Mexico. He serves as the surgical director of renal transplant surgery and the vice chair of clinical affairs for the Department of Surgery at the University of New Mexico School of Medicine.

Dr. Davis earned his MD from the University of New Mexico School of Medicine where he also completed his internship in surgery and his residency in urology. He completed a fellowship in urologic oncology at the University of Miami and Jackson Memorial Hospital in Miami, Florida. Dr. Davis earned an MBA from the University of New Mexico Anderson School of Management in Albuquerque, New Mexico, and he earned an MHA from Colorado State University in Fort Collins, Colorado.

Dr. Davis is a practicing urologist who treats patients in the Albuquerque area. He specializes in kidney transplantation and urologic oncology. Dr. Davis has been an active member of the American Urological Association since 2003. He is also an active member of the American Society of Transplant Surgeons and the American College of Surgeons.

Talks by Michael S. Davis, MD, MBA, MHA, FACS

Will Xenografts Take the Tragedy Out of Transplant

Posted by Michael S. Davis, MD, MBA, MHA, FACS | Nov 2024

Michael S. Davis, MD, MBA, MHA, FACS, examines the potential of renal xenografts to alleviate the organ shortage crisis in transplantation, focusing on developments in pig-to-human kidney transplants.

In this 27-minute presentation, Dr. Davis reviews the history of transplantation, tracing advancements from early animal experiments to the refinement of immunosuppressive therapies and gene editing techniques. He highlights the tragic aspects of current transplantation, noting the limited availability of donor organs. Davis presents recent studies, including preclinical trials at the University of Alabama and NYU, that demonstrated the feasibility of pig kidney transplants in brain-dead human decedents.

With an increasing number of patients awaiting kidney transplants—projected to surpass one million by 2030—the need for innovative solutions like xenotransplantation is urgent. While pig kidneys are favored, barriers such as xeno-antigenic rejection, protein incompatibility, and potential infectious disease transmission remain significant challenges.

The Intersection of Information Technology and Healthcare: Opportunities and Challenges

Posted by Michael S. Davis, MD, MBA, MHA, FACS | Aug 2024

Dr. Davis outlines the ways IT is revolutionizing healthcare delivery. He highlights the role of electronic health records (EHRs), which improve accessibility, accuracy, and coordination of medical information. He notes the adoption of telemedicine, particularly during the COVID-19 pandemic, and its role in providing convenient, accessible, and cost-effective care.

Artificial intelligence (AI) and machine learning are components of the future of healthcare. Dr. Davis explains their applications in predictive analytics, personalized medicine, and diagnostic imaging, where AI algorithms can detect patterns. However, Dr. Davis does not overlook the challenges posed by integrating IT into healthcare, addressing data privacy and security concerns.

Dr. Davis acknowledges the significant initial investment required for IT infrastructure and training but argues that the long-term benefits justify these costs. He advocates for continued investment and innovation in healthcare IT to sustain and enhance its positive impact.

Renal Autotransplant, When All Else Fails

Posted by Michael S. Davis, MD, MBA, MHA, FACS | Oct 2019

Michael S. Davis, MD, provides a brief history of transplant surgery, discusses the indications for renal autotransplant, and reviews proper surgical techniques for this procedure. He also stresses the importance of coordinating with the transplant and vascular surgery team for success in these cases.

Radical Retropubic Prostatectomy: Where Did You Go?

Posted by Michael S. Davis, MD, MBA, MHA, FACS | Jan 2019

Michael S. Davis, MD, reviews the historic shift from radical retropubic prostatectomy (RPP) to a robotic technique dominating practice trends. He discusses the influence of marketing and industry on this trend, as well as cost and outcome benefits of both techniques.